Amphix Bio has received a breakthrough device designation from the US Food ... disease through transforaminal lumbar ...

To follow up on the completion of its clinical proof-of-concept study, SynerFuse™ and its partner, Velentium Medical, today announced plans to scale the patented SynerFuse™ e-TLIF™ procedure implant ...

"Requiring only a single incision and involving direct visual placement of the neurostimulation device will make the SynerFuse™ e-TLIF™ procedure better in terms of patient safety," said ...